title: Treatment perspectives in advanced non-small cell lung cancer.
authors.affiliation: Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Mi. hector.sotoparra@humanitas.it
authors.forename: H
authors.initials: H
authors.lastname: Soto Parra
authors.forename: F
authors.initials: F
authors.lastname: Latteri
authors.forename: R
authors.initials: R
authors.lastname: Cavina
authors.forename: A
authors.initials: A
authors.lastname: Sala
authors.forename: M
authors.initials: M
authors.lastname: Dambrosio
authors.forename: M
authors.initials: M
authors.lastname: Alloisio
authors.forename: A
authors.initials: A
authors.lastname: Santoro
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015687:Cell Hypoxia; D005492:Folic Acid / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D000077150:Oxaliplatin; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005492:Folic Acid